CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Scientists hope genetically modified mice will curb the spread of Lyme disease. They headed to Nantucket — home to a large ...

This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Researchers unveiled a genetic editing method that uses small nuclear RNAs instead of CRISPR. This approach produced fewer ...

The trial's results will be pivotal in determining the therapy’s pharmacological profile and anticoagulant effects.

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

A study using CRISPR restored brain connectivity and made the brain more resilient to seizures, which are often seen in a ...